KEQU (STOCKS)
Kewaunee Scientific Corp
$39.800000
+0.000000 (+0.00%)
Prev close: $39.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Thomas D. Hull
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $114.08M
- Employees
- 1,239
- P/E (TTM)
- 10.10
- P/B (TTM)
- 1.63
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.91 | $0.00 | +0.0000 | +0.00% |
|
Mar 2026 (Q1)
|
$1.10 | $0.00 | +0.0000 | +0.00% |
|
Dec 2025 (Q4)
|
$1.95 | $0.00 | +0.0000 | +0.00% |
|
Sep 2025 (Q3)
|
$1.09 | $0.00 | +0.0000 | +0.00% |
Financial Statements
| Revenues | $285.52M |
| Benefits Costs and Expenses | $269.72M |
| Cost Of Revenue | $202.45M |
| Costs And Expenses | $269.72M |
| Gross Profit | $83.07M |
| Operating Expenses | $63.40M |
| Operating Income/Loss | $19.67M |
| Income/Loss From Continuing Operations After Tax | $11.96M |
| Income/Loss From Continuing Operations Before Tax | $15.80M |
| Income Tax Expense/Benefit | $3.77M |
| Net Income/Loss | $12.03M |
| Net Income/Loss Attributable To Noncontrolling Interest | $285.00K |
| Net Income/Loss Attributable To Parent | $11.74M |
| Net Income/Loss Available To Common Stockholders, Basic | $11.74M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $4.10 |
| Diluted Earnings Per Share | $3.94 |
| Basic Average Shares | 5,729,000 |
| Diluted Average Shares | 5,972,000 |
| Assets | $189.08M |
| Current Assets | $113.64M |
| Inventory | $35.50M |
| Other Current Assets | $78.14M |
| Noncurrent Assets | $75.44M |
| Fixed Assets | $23.16M |
| Intangible Assets | $17.06M |
| Other Non-current Assets | $35.22M |
| Liabilities | $117.36M |
| Current Liabilities | $45.81M |
| Accounts Payable | $22.66M |
| Wages | $7.62M |
| Other Current Liabilities | $15.53M |
| Noncurrent Liabilities | $71.55M |
| Long-term Debt | $35.25M |
| Other Non-current Liabilities | $36.30M |
| Equity | $71.72M |
| Equity Attributable To Noncontrolling Interest | $1.87M |
| Equity Attributable To Parent | $69.85M |
| Liabilities And Equity | $189.08M |
| Net Cash Flow From Operating Activities | $8.67M |
| Net Cash Flow From Operating Activities, Continuing | $8.67M |
| Net Cash Flow From Investing Activities | -$32.28M |
| Net Cash Flow From Investing Activities, Continuing | -$32.28M |
| Net Cash Flow From Financing Activities | $7.98M |
| Net Cash Flow From Financing Activities, Continuing | $7.98M |
| Exchange Gains/Losses | -$352.00K |
| Net Cash Flow | -$15.99M |
| Net Cash Flow, Continuing | -$15.63M |
| Comprehensive Income/Loss | $11.22M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $285.00K |
| Comprehensive Income/Loss Attributable To Parent | $10.94M |
| Other Comprehensive Income/Loss | -$803.00K |